CETP inhibitors

NewAmsterdam drug shows ‘unexpected’ signs of protecting the heart in latest study
BioPharma Dive
Tue, 12/10/24 - 10:11 pm
NewAmsterdam Pharma
obicetrapib
CETP inhibitors
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
NewAmsterdam Pharma
Amgen
CETP inhibitors
obicetrapib
clinical trials
Thought CETP inhibition was dead? Think again
EP Vantage
Sat, 04/23/22 - 04:17 pm
New Amsterdam
Amgen
CETP inhibitors
obicetrapib
A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid
Endpoints
Thu, 01/14/21 - 10:45 am
Eli Lilly
cardiovascular disease
NewAmsterdam Pharma
CETP inhibitors
Amgen buries the last big CETP drug, marking the bitter end of a blockbuster quest
Endpoints
Fri, 10/27/17 - 11:12 am
Amgen
drug development
CETP inhibitors
Dezima
Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Endpoints
Wed, 10/11/17 - 11:05 pm
Merck
Anacetrapib
clinical trials
CETP inhibitors
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results?
Xconomy
Tue, 08/29/17 - 11:24 am
Merck
FDA
Anacetrapib
CETP inhibitors
Why a drug that lowers cholesterol doesn’t save lives
Stat
Thu, 05/19/16 - 03:40 pm
cholesterol
heart disease
CETP inhibitors
Eli Lilly
evacetrapib
Pfizer
Torcetrapib
Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages
Bidness, ETC
Thu, 10/15/15 - 09:41 am
Merck
Eli Lilly
CETP inhibitors
Anacetrapib
evacetrapib
Did Amgen Waste $300 Million In Buying A Flawed Heart Drug?
Forbes
Mon, 10/12/15 - 01:39 pm
Amgen
Eli Lilly
evacetrapib
CETP inhibitors
Dezima
TA-8995
Are Cholesterol Drugs In For Another Revolution?
Investors.com
Wed, 10/7/15 - 03:28 pm
CETP inhibitors
PCSK9 inhibitors
Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?
Forbes
Thu, 09/17/15 - 10:18 am
Amgen
Dezima
CETP inhibitors
Pfizer
M&A
Esperion Therapeutics
Can The Dutch Biotech Dezima Really Impact Heart Disease With Its HDL-Raising Drug?
Forbes
Tue, 09/2/14 - 09:49 am
Dezima
heart disease
CETP inhibitors
TA-8995
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Fri, 01/25/13 - 11:05 am
CETP inhibitors
Merck
Anacetrapib
Torcetrapib
Pfizer
Roche
dalceptrapib
Roche’s Good Cholesterol Drug Shows Negative Side Effects
Bloomberg
Mon, 11/5/12 - 04:59 pm
Roche
dalcetrapib
CETP inhibitors
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sun, 11/20/11 - 12:14 pm
CETP inhibitors
Merck
Roche
Eli Lilly
Anacetrapib
dalcetrapib
evacetrapib
Will Merck Succeed Where Pfizer Did Not?
Seeking Alpha
Thu, 02/10/11 - 09:11 am
Pfizer
Merck
CETP inhibitors
Anacetrapib
Torcetrapib
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Bloomberg
Sat, 11/27/10 - 01:17 pm
Merck
Pfizer
CETP inhibitors
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Sat, 11/20/10 - 12:20 pm
Merck
CETP inhibitors
Anacetrapib
cholesterol
Merck Restarts Cholesterol Race Four Years After Pfizer Failure
Bloomberg
Wed, 11/10/10 - 08:19 am
Merck
Pfizer
cholesterol
CETP inhibitors